Catalyst Biosciences Receives Patents Covering its Hemostasis and Anti-Complement Programs
Go back to Catalyst Biosciences Receives Patents Covering its Hemostasis and Anti-Complement Programs| (NASDAQ: CBIO) | Delayed: 12.76 -0.06 (0.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.82 | 52 Week High | $4.57 | |||
| Open | $12.87 | 52 Week Low | $0.62 | |||
| Day High | $13.27 | P/E | N/A | |||
| Day Low | $12.50 | EPS | $0.00 | |||
| Volume | 210,637 | |||||



